Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention‐Deficit/Hyperactivity Disorder

por Clemow, David B., Nyhuis, Allen W., Robinson, Rebecca L.
Publicado 2016

Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study

por Adler, Lenard A., Clemow, David B., Williams, David W., Durell, Todd M.
Publicado 2014

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

por Clemow, David B, Bushe, Chris, Mancini, Michele, Ossipov, Michael H, Upadhyaya, Himanshu
Publicado 2017

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder

por Kabul, Samaneh, Alatorre, Carlos, Montejano, Leslie B., Farr, Amanda M., Clemow, David B.
Publicado 2015

Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled,...

por Wietecha, Linda A., Clemow, David B., Buchanan, Andrew S., Young, Joel L., Sarkis, Elias H., Findling, Robert L.
Publicado 2016

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist

por Clemow, David B., Johnson, Kirk W., Hochstetler, Helen M., Ossipov, Michael H., Hake, Ann M., Blumenfeld, Andrew M.
Publicado 2020

Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement...

por Dubinsky, Marla C, Clemow, David B, Hunter Gibble, Theresa, Li, Xingyuan, Vermeire, Severine, Hisamatsu, Tadakazu, Travis, Simon P L
Publicado 2022